SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-154347
Filing Date
2023-05-25
Accepted
2023-05-25 17:05:30
Documents
13
Period of Report
2023-05-25
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d462773d8k.htm   iXBRL 8-K 40787
2 EX-99.1 d462773dex991.htm EX-99.1 32625
  Complete submission text file 0001193125-23-154347.txt   218202

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cgem-20230525.xsd EX-101.SCH 2878
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cgem-20230525_lab.xml EX-101.LAB 20212
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cgem-20230525_pre.xml EX-101.PRE 12609
7 EXTRACTED XBRL INSTANCE DOCUMENT d462773d8k_htm.xml XML 3713
Mailing Address ONE MAIN STREET SUITE 1350 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 1350 CAMBRIDGE MA 02142 617-410-4650
Cullinan Oncology, Inc. (Filer) CIK: 0001789972 (see all company filings)

IRS No.: 813867811 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39856 | Film No.: 23961891
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences